[Successful selpercatinib treatment of metastatic medullary thyroid cancer carrying rare RET variant].

Abstract excerpt

AIM: Medullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy in which serum calcitonin plays a pivotal role in early diagnosis, surgical planning, guidance of systemic therapy, and monitoring of treatment response. This case highlights the importance of laboratory diagnostics during selpercatinib therapy in a patient with disseminated MTC harboring a rare RET pathogenic variant. METHODS: A cervical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calcitonin
• Share to Carcinoma, Neuroendocrine